Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells.
The RON receptor tyrosine kinase is a 180 kDa heterodimeric protein composed of a 40 kDa alpha chain and a 145 kDa beta chain with intrinsic tyrosine kinase activity. Activation of RON causes cell dissociation, motility and invasion of extracellular matrices, suggesting that RON might be involved in tumor metastasis. We report here the cloning of a novel splice variant of RON in human colorectal carcinoma cell line HT-29. This RON variant is first produced as a single chain precursor with a molecular mass of 160 kDa. Proteolytic cleavage results in a 40 kDa alpha chain and a short form of the beta chain with a molecular mass of 125 kDa. The altered receptor is synthesized from a transcript differing from the full-length RON mRNA by an in-frame deletion of 109 amino acids in the extracellular domain of the RON beta chain. The consequence of the deletion is constitutive activation of the protein with autophosphorylation. Expression of the RON variant in colon epithelial CoTr cells results in increased cell migration and invasion of extracellular matrices. These data suggest that generation of the activated splice variant of RON may contribute to the invasive phenotype of human colorectal carcinomas in vivo.
Department of Medicine, University of Colorado School of Medicine and Denver Health Medical Center, 777 Bannock Street, Denver, CO 80204, USA. ming-hai.wang@uchsc.edu
M H
MH
Wang
A L
AL
Kurtz
Y
Y
Chen
D017398:Alternative Splicing; D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D002461:Cell Line, Transformed; D002465:Cell Movement / Q000502:physiology; D003001:Cloning, Molecular; D003094:Collagen; D003106:Colon / Q000166:cytology / Q000201:enzymology / Q000502:physiology; D004273:DNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D004338:Drug Combinations; D004789:Enzyme Activation; D004847:Epithelial Cells / Q000166:cytology / Q000201:enzymology / Q000502:physiology; D005109:Extracellular Matrix / Q000502:physiology; D019073:HT29 Cells / Q000201:enzymology* / Q000473:pathology; D006801:Humans; D007797:Laminin; D008969:Molecular Sequence Data; D009361:Neoplasm Invasiveness; D010641:Phenotype; D011509:Proteoglycans; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D011956:Receptors, Cell Surface / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D014162:Transfection
D004273:DNA, Neoplasm; D004338:Drug Combinations; D007797:Laminin; D011509:Proteoglycans; D011956:Receptors, Cell Surface; C059485:matrigel; D003094:Collagen; C080835:RON protein; D020794:Receptor Protein-Tyrosine Kinases